Stock & Company Details
Benitec Biopharma Inc $BNTC
Price:
N/A
N/A
35M
$307M
52 Week High:
N/A
10 Day Average Volume:
N/A
-7.97
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BNTC technical indicators
Latest Benitec Biopharma Inc (BNTC) indicator readings as of 2026-10-29.
BNTC's 14-day RSI is 43.7, in neutral territory. At $8.83 it is trading 23.6% below its 200-day moving average of $11.56, and below its 50-day average of $10.48. Price sits in the middle of its Bollinger Bands ($8.17 to $9.30). ADX reads 32.2, indicating a trending market.
Overview
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.
Finance Bot
Ask your questions
Start by typing a question below.
